Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
161M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
44.1M
-
Shares change
-
+10.7M
-
Total reported value, excl. options
-
$152M
-
Value change
-
+$37.4M
-
Put/Call ratio
-
0.44
-
Number of buys
-
54
-
Number of sells
-
-33
-
Price
-
$3.45
Significant Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q4 2022
103 filings reported holding GRTS - Gritstone bio, Inc. - Common Stock, $0.0001 par value per share as of Q4 2022.
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.1M shares
of 161M outstanding shares and own 27.46% of the company stock.
Largest 10 shareholders include Point72 Asset Management, L.P. (7.68M shares), Redmile Group, LLC (6.93M shares), Frazier Life Sciences Management, L.P. (5.16M shares), Versant Venture Management, LLC (3.56M shares), VANGUARD GROUP INC (3.19M shares), Balyasny Asset Management LLC (2.05M shares), MORGAN STANLEY (1.99M shares), BlackRock Inc. (1.95M shares), Assenagon Asset Management S.A. (1.95M shares), and Artal Group S.A. (1.86M shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.